{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:13:00Z","timestamp":1761883980027,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.reumae.2021.04.017","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T07:40:52Z","timestamp":1669275652000},"page":"597-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Study the Relationship of MDCT Staging in Disease Extent with the Systemic Sclerosis Disease Parameters"],"prefix":"10.1016","volume":"18","author":[{"given":"Abeer M.","family":"Ghandour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania M.","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gehan Seif","family":"Eldein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya M.","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"El-Hakeim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa A.A.","family":"Galal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma H.","family":"El-Nouby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmine S.","family":"Makarem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Abdellatif","family":"Awad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A.","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan Sayed M.","family":"Abozaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2021.04.017_bib0175","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.autrev.2016.07.025","article-title":"Pulmonary involvement in systemic sclerosis","volume":"15","author":"Morales-C\u00e1rdenas","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reumae.2021.04.017_bib0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1183\/09059180.00005512","article-title":"Scleroderma lung disease","volume":"22","author":"Solomon","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.reumae.2021.04.017_bib0185","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeROY","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2021.04.017_bib0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ccm.2010.05.004","article-title":"Pulmonary manifestations of scleroderma and mixed connective tissue disease","volume":"31","author":"Hant","year":"2010","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.reumae.2021.04.017_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/berh.1999.0074","article-title":"Systemic sclerosis (scleroderma) and related disorders: clinical aspects","volume":"14","author":"Clements","year":"2000","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.reumae.2021.04.017_bib0200","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/radiology.176.3.2389033","article-title":"Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography","volume":"176","author":"Schurawitzki","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.reumae.2021.04.017_bib0205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/art.1780280706","article-title":"Pulmonary involvement in systemic sclerosis (scleroderma)","volume":"28","author":"Steen","year":"1985","journal-title":"Arthrit Rheumatol"},{"key":"10.1016\/j.reumae.2021.04.017_bib0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.22532","article-title":"Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors","volume":"57","author":"Mcnearney","year":"2007","journal-title":"Arthrit Care Res"},{"key":"10.1016\/j.reumae.2021.04.017_bib0215","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.114.3.801","article-title":"African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease","volume":"114","author":"Greidinger","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.reumae.2021.04.017_bib0220","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1183\/09059180.00006111","article-title":"Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening","volume":"20","author":"Denton","year":"2011","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.reumae.2021.04.017_bib0225","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthrit Rheum"},{"issue":"Suppl. 29","key":"10.1016\/j.reumae.2021.04.017_bib0230","first-page":"S42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reumae.2021.04.017_bib0235","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201710-1981ST","article-title":"Recommendations for a standardized pulmonary function report. An official American Thoracic Society technical statement","volume":"196","author":"Culver","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.reumae.2021.04.017_bib0240","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1164\/ajrccm.157.5.9609096","article-title":"Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis","volume":"157","author":"Wells","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.reumae.2021.04.017_bib0245","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1148\/radiol.2322031223","article-title":"CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia","volume":"232","author":"Desai","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.reumae.2021.04.017_bib0250","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2021.04.017_bib0255","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma)","volume":"46","author":"D\u2019Angelo","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.reumae.2021.04.017_bib0260","first-page":"490","article-title":"Pulmonary scleroderma","volume":"54","author":"Weaver","year":"1968","journal-title":"Chest"},{"key":"10.1016\/j.reumae.2021.04.017_bib0265","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10067-006-0302-6","article-title":"The natural course of progressive systemic sclerosis patients with interstitial lung involvement","volume":"26","author":"Benan","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2021.04.017_bib0270","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","article-title":"Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome","volume":"165","author":"Bouros","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.reumae.2021.04.017_bib0275","first-page":"878","article-title":"The relevance of high-resolution computed tomographic findings and pulmonary arterial hypertension in systemic sclerosis-associated interstitial lung disease","volume":"97","author":"Wangkaew","year":"2014","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.reumae.2021.04.017_bib0280","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/art.30438","article-title":"Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease","volume":"63","author":"Roth","year":"2011","journal-title":"Arthrit Rheum"},{"key":"10.1016\/j.reumae.2021.04.017_bib0285","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.reumae.2021.04.017_bib0290","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/art.30467","article-title":"Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group","volume":"63","author":"Khanna","year":"2011","journal-title":"Arthrit Rheumatol"},{"key":"10.1016\/j.reumae.2021.04.017_bib0295","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s00330-011-2223-2","article-title":"Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide","volume":"21","author":"Kim","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.reumae.2021.04.017_bib0300","first-page":"229","article-title":"High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis","volume":"18","author":"Patiwetwitoon","year":"2012","journal-title":"JCR: J Clin Rheumatol"},{"key":"10.1016\/j.reumae.2021.04.017_bib0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0872-2","article-title":"Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials","volume":"17","author":"Khanna","year":"2015","journal-title":"Arthrit Res Therapy"},{"key":"10.1016\/j.reumae.2021.04.017_bib0310","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/art.39405","article-title":"Brief report: Pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease","volume":"67","author":"Suliman","year":"2015","journal-title":"Arthrit Rheumatol"},{"key":"10.1016\/j.reumae.2021.04.017_bib0315","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/ard.2007.069518","article-title":"Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis","volume":"66","author":"Clements","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2021.04.017_bib0320","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","article-title":"Severe restrictive lung disease in systemic sclerosis","volume":"37","author":"Steen","year":"1994","journal-title":"Arthrit Rheumatol"},{"key":"10.1016\/j.reumae.2021.04.017_bib0325","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-132-12-200006200-00004","article-title":"Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis","volume":"132","author":"White","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.reumae.2021.04.017_bib0330","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1378\/chest.08-0053","article-title":"Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival","volume":"134","author":"Fischer","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.reumae.2021.04.017_bib0335","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1568-9972(03)00004-1","article-title":"New insights into the pathogenesis of systemic sclerosis","volume":"2","author":"Tamby","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reumae.2021.04.017_bib0340","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U","article-title":"Improvement in skin thickening in systemic sclerosis associated with improved survival","volume":"44","author":"Steen","year":"2001","journal-title":"Arthrit Rheumatol"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574322001605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574322001605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:01:47Z","timestamp":1761879707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574322001605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2173574322001605"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2021.04.017","relation":{},"ISSN":["2173-5743"],"issn-type":[{"type":"print","value":"2173-5743"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study the Relationship of MDCT Staging in Disease Extent with the Systemic Sclerosis Disease Parameters","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2021.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2021.04.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}